Source: UNIVERSITY OF GEORGIA submitted to NRP
PATHOGENESIS AND VIRULENCE OF A BOVINE ENTEROVIRUS-1 ISOLATE IN CATTLE
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
0211728
Grant No.
(N/A)
Cumulative Award Amt.
(N/A)
Proposal No.
(N/A)
Multistate No.
(N/A)
Project Start Date
Oct 1, 2006
Project End Date
Sep 30, 2008
Grant Year
(N/A)
Program Code
[(N/A)]- (N/A)
Recipient Organization
UNIVERSITY OF GEORGIA
200 D.W. BROOKS DR
ATHENS,GA 30602-5016
Performing Department
COLLEGE OF VETERINARY MEDICINE
Non Technical Summary
Very little is known about the pathogenesis and virulence of BEV-1 in cattle. While early reports concerning the virulence of BEV have suggested that there might be an association between BEV infections and a range of diseases in cattle, as viruses were isolated from cattle with clinical signs that varied from respiratory to enteric to reproductive disease and infertility, nowhere have results been published reporting the status of either individual animals or groups of animals experimentally infected with virulent BEV-1, the lesions associated with infection and disease, or its pathogenesis in cattle. Having knowledge about the susceptibility of calves to challenge, about of the pathology associated with infection, if any, and about the prevalence of BEV-1 infection in herds in the state Georgia will be essential for the understanding and characterization of this pathogen in U.S. cattle. The absence of studies on the pathogenesis of BEV and of its prevalence in cattle warrants further studies on the possible pathogenic significance of BEV.
Animal Health Component
25%
Research Effort Categories
Basic
50%
Applied
25%
Developmental
25%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
31139991101100%
Knowledge Area
311 - Animal Diseases;

Subject Of Investigation
3999 - Animal research, general;

Field Of Science
1101 - Virology;
Goals / Objectives
The main objective of this study is to test the hypothesis that the BEV-1 Oklahoma isolate is virulent to susceptible cattle. Specific aims include: 1.To describe clinical signs (if any) associated with acute BEV-1 infection in calves 2.To characterize laboratory clinical parameter alterations (if any) associated with acute BEV-1 infection 3.To characterize fecal shedding of enterovirus following challenge 4.To characterize the gross and microscopic tissue alterations (if any) associated with BEV-1 Oklahoma isolate infection 5.To develop techniques, such as serum neutralization, real-time PCR, in situ hybridization, as diagnostic tests for the detection and further characterization of BEV-1.
Project Methods
Eighteen, 8 to 12 week-old, male dairy calves will be used for this study. All experimental calves will be screened for antibody against BEV-1 using the serum neutralization test and only calves with a negative titer (<1:4) will be used. Three groups of 3 male dairy calves each will be inoculated intranasally with 10-7 tissue culture infective doses (TCID-50) of BEV-1 in the form of Madin Darby bovine kidney (MDBK)-infected cell culture supernatant fluid. Three groups of 3 male calves each will be inoculated with uninfected MDBK cell culture supernatant fluid to serve as controls. To identify potential route of entry and early changes, 3 controls and 3 infected claves will be necropsied at 4 hours (Day 0) post inoculation and on days 5 and 10 PI. The response of calves to BEV-1 infection will be followed by clinical observation (aim 1), hematological studies and fecal cultures (aim 2), necropsy and histopathology (aim 4). Infection of calves will be confirmed by real-time PCR, isolation and propagation in MDBK cell cultures and in-situ hybridization (aims 3 and 5).

Progress 10/01/06 to 09/30/08

Outputs
OUTPUTS: During this period, a third and last experiment was conducted and completed with the main objective of testing the hypothesis that BEV-1 Oklahoma isolate is virulent to cattle. In this experiment, 18, 8-12 week old calves were divided into 3 groups of 6 calves each. Calves were kept in separate pens. Blindly, in each group, 4 calves were inoculated intranasally with 1 ml of virus-infected media and 2 calves were inoculated with 1 ml of non-infected media (placebo). Calves were observed for clinical signs, and then euthanized at 4 hours, 5 days, and 10 days post inoculation. A complete necropsy was performed in each animal, and samples of blood, feces, and fresh tonsils, small intestine, large intestine, mesenteric lymph nodes, lung, liver, spleen, and kidney were subjected to laboratory analysis. PARTICIPANTS: Jeremiah T. Saliki - Virologist, developed virus isolation and serology assays Susan Sanchez - Molecular Microbiologist, developed molecular tests, PCR assay Corrie C. Brown - Pathologist, helped with evaluation of tissues; in-situ hybridization assay Amelia Woolums - Bovine Veterinarian, performed clinical evaluation of calves Jian Zhang - Laboratorian, developed and performed the in-situ hybridization Deborah Keys - Study Statistician, helped in the study design TARGET AUDIENCES: Veterinary Diagnosticians and Pathologists - These audiences are to be targeted through seminars and publications in major journals PROJECT MODIFICATIONS: Nothing significant to report during this reporting period.

Impacts
None of the infected calves had clinical or postmortem evidence of disease. Microscopic lesions were few and mild and were limited to the spiral colon of the large intestine; these consisted of mild multifocal inflammation and hemorrhage and predominantly occurred in calves at 5 days post inoculation. Seroconversion to BEV-1 was noted in virus-infected calves at 5 and 10 days post inoculation. BEV-1 was isolated from feces and colon of most infected animals at 5 and 10 days post infection. Two placebo inoculated calves were positive for virus isolation from the colon and feces. PCR testing detected BEV-1 only in the large intestine; results were very strong in most virus inoculated calves at 5 and 10 days post inoculation. The same two placebo inoculated calves that tested positive for virus isolation from the colon and feces were also strongly positive through PCR testing. Findings indicate that the BEV-1 isolate tested is capable of infecting cattle; that under the tested conditions, the virus is able to infect cells of the large intestine, from which the virus replicates and is shed to the environment; and that the virus is infectious to other animals. The contribution of the current study is to add to current knowledge of the pathogenesis of viruses that can potentially affect the US and Georgia cattle populations. Currently, testing of formalin fixed, paraffin embedded tissue for the presence of virus through in-situ hybridization and immunohistochemistry, is underway. Results will be published.

Publications

  • No publications reported this period


Progress 01/01/07 to 12/31/07

Outputs
OUTPUTS: With the main objective of testing the hypothesis that the BEV-1 Oklahoma isolate is virulent to susceptible cattle, two initial experiments were conducted and completed. A thrid experiment was planned but not conducted. PARTICIPANTS: Jeremiah T. Saliki, Corrie C. Brown, Susan Sanchez, Amelia Woolums, Deborah Keys, Jian Zhang

Impacts
Inital experiments allowed to describe clinical signs associated with acute BEV-1 infection in calves, to partially characterize the fecal shedding that occurs following challenge, to partially characterize the gross and microscopic tissue alterations associated with BEV-1 Oklahoma isolate infection, and to develop some techniques, such as serum neutralization and viral isolation in cell culture. Because an additional experiment has not been conducted yet, evaluation of laboratory clinical parameter alterations (if any) associated with acute BEV-1 infection and developmet of other techniques, such as real-time PCR, in situ hybridization, and other diagnostic tests for the detection and further characterization of BEV-1 have not been developed. Thus far, experimental results indicated that at the effective dose, experimental animals were infected with the virus; animals developed a detectable SN titers to the virus; and virus was recovered from the feces of infected animals. Experimental findings suggest that bovine enterovirus isolate used is able to infect experimental animals and that such animals are able to, potentyially, transmit the virus to suceptible animals.

Publications

  • No publications reported this period